Author

M. Jang

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Research Focus:variant calling· 1

Frequent Co-Authors

A. Kim· 1 shared B. C. Cho· 1 shared B. Carreno· 1 shared C.-B. Synn· 1 shared E. Kim· 1 shared H. Lee· 1 shared H. S. Kim· 1 shared J. I. Lee· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Kim

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

In vitro validation of neoantigen prediction algorithm for developing personalized cancer vaccine therapy

Y.-j. Choe, E. Kim, J. Oh, M. Jang, W. Fu, H. Lee, M. Jung, K.-H. Pyo, C.-B. Synn, S. Kim, Y. Yang, A. Kim, B. C. Cho, H. S. Kim, S. Kim, , S. Paik

The paper validates a neoantigen prediction algorithm, Neopepsee, by testing its immunogenicity using ELISpot assays on patient-derived samples and compares it to pVACseq.

bioRxiv · Dec 12, 2021 · PreprintImmunology

Lopinavir-ritonavir is not an effective inhibitor of the main protease activity of SARS-CoV-2 in vitro

M. Jang, Y.-I. Park, R. Park, Y.-E. Cha, S. Namkoong, J. I. Lee, J. Park

This study shows lopinavir and ritonavir do not inhibit SARS-CoV-2 main protease activity in vitro, suggesting they may not be effective for COVID-19 treatment.

bioRxiv · Sep 16, 2020 · PreprintMicrobiology